Patterns of Repeat Prostate Biopsy in Contemporary Clinical Practice

被引:80
作者
Abraham, Nitya E. [1 ]
Mendhiratta, Neil [1 ]
Taneja, Samir S. [1 ]
机构
[1] NYU, Sch Med, Dept Urol, Div Urol Oncol, New York, NY 10003 USA
关键词
prostate; prostatic neoplasms; biopsy; magnetic resonance imaging; diagnosis; CANCER-DETECTION; RADICAL PROSTATECTOMY; ULTRASOUND FUSION; SEXTANT BIOPSIES; RISK-ASSESSMENT; NEEDLE-BIOPSY; RECURRENCE; ANTIGEN; MEN;
D O I
10.1016/j.juro.2014.10.084
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The objectives of this study were to 1) describe the patterns of repeat prostate biopsy in men with a previous negative biopsy and 2) identify predictors of prostate cancer diagnosis on repeat biopsy in these men. Materials and Methods: From a university faculty group practice we identified 1,837 men who underwent prostate biopsy between January 1, 1995 and January 1, 2010. Characteristics of repeat biopsy were examined, including the indication for biopsy, the number of repeat biopsies performed, the number of cores obtained and total prostate specific antigen before biopsy. Features of prostate cancer diagnosed on repeat biopsy were examined, including Gleason score, number of positive cores, percent of tumor and treatment choice. Multivariable logistic regression was done to identify prostate cancer predictors. Results: Initial biopsy was negative in 1,213 men. In 255 men a total of 798 repeat biopsies were performed. Of the 63 men diagnosed with prostate cancer Gleason score was 6 or less in 33 (52%), 7 in 22 (35%) and 8-9 in 8 (13%). When categorized by Epstein criteria, the rate of clinically insignificant cancer diagnosis decreased substantially by the third and fourth repeat biopsies. Repeat biopsy in men older than 70 years, biopsies including more than 20 cores and the fourth repeat biopsy were associated with an increased likelihood of prostate cancer diagnosis. Conclusions: In men selected for multiple repeat biopsies clinically significant cancer is found at each sampling round. Given the continued likelihood of cancer detection even by the fifth biopsy, early consideration of saturation or image guided biopsy may be warranted in the repeat biopsy population.
引用
收藏
页码:1178 / 1184
页数:7
相关论文
共 28 条
[1]   Effect of Dutasteride on the Risk of Prostate Cancer. [J].
Andriole, Gerald L. ;
Bostwick, David G. ;
Brawley, Otis W. ;
Gomella, Leonard G. ;
Marberger, Michael ;
Montorsi, Francesco ;
Pettaway, Curtis A. ;
Tammela, Teuvo L. ;
Teloken, Claudio ;
Tindall, Donald J. ;
Somerville, Matthew C. ;
Wilson, Timothy H. ;
Fowler, Ivy L. ;
Rittmaster, Roger S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (13) :1192-1202
[2]  
[Anonymous], 2014, PROST CANC EARL DET
[3]   Optimization of Prostate Biopsy: the Role of Magnetic Resonance Imaging Targeted Biopsy in Detection, Localization and Risk Assessment [J].
Bjurlin, Marc A. ;
Meng, Xiaosong ;
Le Nobin, Julien ;
Wysock, James S. ;
Lepor, Herbert ;
Rosenkrantz, Andrew B. ;
Taneja, Samir S. .
JOURNAL OF UROLOGY, 2014, 192 (03) :648-658
[4]   Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies [J].
Borboroglu, PG ;
Comer, SW ;
Riffenburgh, RH ;
Amling, CL .
JOURNAL OF UROLOGY, 2000, 163 (01) :158-162
[5]   Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy [J].
Campos-Fernandes, Jean-Louis ;
Bastien, Laurence ;
Nicolaiew, Nathalie ;
Robert, Gregoire ;
Terry, Stephane ;
Vacherot, Francis ;
Salomon, Laurent ;
Allory, Yves ;
Vordos, Dimitri ;
Hoznek, Andras ;
Yiou, Rene ;
Patard, Jean Jacques ;
Abbou, Claude Clement ;
de la Taille, Alexandre .
EUROPEAN UROLOGY, 2009, 55 (03) :600-609
[6]   The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy [J].
Cooperberg, MR ;
Pasta, DJ ;
Elkin, EP ;
Litwin, MS ;
Latini, DM ;
DuChane, J ;
Carroll, PR .
JOURNAL OF UROLOGY, 2005, 173 (06) :1938-1942
[7]   Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? [J].
Djavan, B ;
Ravery, V ;
Zlotta, A ;
Dobronski, P ;
Dobrovits, M ;
Fakhari, M ;
Seitz, C ;
Susani, M ;
Borkowski, A ;
Boccon-Gibod, L ;
Schulman, CC ;
Marberger, M .
JOURNAL OF UROLOGY, 2001, 166 (05) :1679-1683
[8]  
Djavan Bob, 2005, Can J Urol, V12 Suppl 1, P44
[9]   A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands [J].
Gupta, A. ;
Roobol, M. J. ;
Savage, C. J. ;
Peltola, M. ;
Pettersson, K. ;
Scardino, P. T. ;
Vickers, A. J. ;
Schroder, F. H. ;
Lilja, H. .
BRITISH JOURNAL OF CANCER, 2010, 103 (05) :708-714
[10]  
Gupta RT, 2013, ONCOLOGY-NY, V27, P262